AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Should We Be Giving Fluid Restrictive Protocols or Trials in Africa?
I actually didn't see the we haven't seen the mortality data from the interim analysis. No okay. So I don't know. The lot perhaps you have one more yet please. What's the take for researchers and clinician in low and middle income countries? Starting from peace then Andrews classic all other trials do we need a classic LMIC trial or is the aggregate evidence enough to just go restrictive)? That's a really good question. Please go ahead.